Tower Research Capital LLC (Trc) Biomarin Pharmaceutical Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,204 shares of BMRN stock, worth $503,734. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,204
Previous 5,782 59.18%
Holding current value
$503,734
Previous $317,000 57.1%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$52.62 - $61.93 $180,065 - $211,924
3,422 Added 59.18%
9,204 $498,000
Q2 2025

Aug 14, 2025
SELL
$54.08 - $68.32 $253,310 - $320,010
-4,684 Reduced 44.75%
5,782 $317,000
Q1 2025

May 15, 2025
SELL
$61.25 - $72.83 $399,717 - $475,288
-6,526 Reduced 38.41%
10,466 $739,000
Q4 2024

Feb 13, 2025
BUY
$61.93 - $70.49 $831,472 - $946,398
13,426 Added 376.5%
16,992 $1.12 Million
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $1.53 Million - $2.09 Million
-22,232 Reduced 86.18%
3,566 $250,000
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $1.88 Million - $2.33 Million
25,296 Added 5039.04%
25,798 $2.12 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $251,094 - $296,604
-2,996 Reduced 85.65%
502 $43,000
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $407,700 - $526,929
-5,349 Reduced 60.46%
3,498 $337,000
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $336,536 - $373,762
-3,956 Reduced 30.9%
8,847 $782,000
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $646,719 - $748,338
7,461 Added 139.67%
12,803 $1.11 Million
Q1 2023

May 09, 2023
BUY
$87.74 - $117.27 $193,554 - $258,697
2,206 Added 70.34%
5,342 $520,000
Q4 2022

Feb 10, 2023
BUY
$80.93 - $108.63 $184,601 - $247,785
2,281 Added 266.78%
3,136 $324,000
Q3 2022

Nov 10, 2022
SELL
$82.16 - $96.94 $782,820 - $923,644
-9,528 Reduced 91.77%
855 $73,000
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $59,685 - $72,519
835 Added 8.75%
10,383 $861,000
Q1 2022

May 12, 2022
BUY
$74.28 - $92.69 $256,043 - $319,502
3,447 Added 56.5%
9,548 $736,000
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $334,502 - $426,616
4,664 Added 324.57%
6,101 $539,000
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $178,027 - $203,504
-2,381 Reduced 62.36%
1,437 $111,000
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $1.44 Million - $1.61 Million
-19,047 Reduced 83.3%
3,818 $319,000
Q1 2021

May 17, 2021
BUY
$74.73 - $90.69 $1.09 Million - $1.33 Million
14,650 Added 178.33%
22,865 $1.73 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $144,856 - $179,949
1,995 Added 32.07%
8,215 $721,000
Q3 2020

Nov 16, 2020
BUY
$71.87 - $131.03 $267,284 - $487,300
3,719 Added 148.7%
6,220 $473,000
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $198,954 - $310,674
2,501 New
2,501 $308,000
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $8,136 - $11,040
-114 Closed
0 $0
Q4 2019

Feb 07, 2020
SELL
$64.27 - $86.37 $67,804 - $91,120
-1,055 Reduced 90.25%
114 $10,000
Q3 2019

Nov 05, 2019
SELL
$67.4 - $85.11 $38,552 - $48,682
-572 Reduced 32.85%
1,169 $79,000
Q2 2019

Aug 13, 2019
BUY
$80.35 - $93.9 $84,929 - $99,252
1,057 Added 154.53%
1,741 $150,000
Q1 2019

May 14, 2019
BUY
$84.2 - $98.62 $49,593 - $58,087
589 Added 620.0%
684 $60,000
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $515,620 - $682,454
-6,434 Reduced 98.54%
95 $8,000
Q3 2018

Nov 13, 2018
BUY
$93.92 - $105.72 $197,513 - $222,329
2,103 Added 47.51%
6,529 $633,000
Q2 2018

Aug 15, 2018
BUY
$76.01 - $99.03 $195,041 - $254,110
2,566 Added 137.96%
4,426 $417,000
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $110,990 - $132,368
-1,429 Reduced 43.45%
1,860 $151,000
Q4 2017

Feb 09, 2018
BUY
$80.76 - $95.13 $172,341 - $203,007
2,134 Added 184.76%
3,289 $293,000
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $93,093 - $109,667
1,155
1,155 $107,000

Others Institutions Holding BMRN

# of Institutions
656
Shares Held
182M
Call Options Held
1.48M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email